These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21098981)

  • 21. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment.
    Nobili F; De Carli F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Morbelli S; Guerra UP; Dessi B; Brugnolo A; Visser PJ
    J Alzheimers Dis; 2009; 17(4):761-72. PubMed ID: 19542623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical changes in incipient Alzheimer's disease.
    Prestia A; Drago V; Rasser PE; Bonetti M; Thompson PM; Frisoni GB
    J Alzheimers Dis; 2010; 22(4):1339-49. PubMed ID: 20930288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment.
    Baldeiras I; Santana I; Proença MT; Garrucho MH; Pascoal R; Rodrigues A; Duro D; Oliveira CR
    J Alzheimers Dis; 2010; 21(4):1165-77. PubMed ID: 21504121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.
    Mosconi L; Tsui WH; De Santi S; Li J; Rusinek H; Convit A; Li Y; Boppana M; de Leon MJ
    Neurology; 2005 Jun; 64(11):1860-7. PubMed ID: 15955934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.
    Liu Y; Paajanen T; Zhang Y; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    Neurobiol Aging; 2010 Aug; 31(8):1375-85. PubMed ID: 20447732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
    Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
    Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
    Ishii H; Ishikawa H; Meguro K; Tashiro M; Yamaguchi S
    Int Psychogeriatr; 2009 Feb; 21(1):148-56. PubMed ID: 19040787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically different stages of Alzheimer's disease associated by amyloid deposition with [11C]-PIB PET imaging.
    Hatashita S; Yamasaki H
    J Alzheimers Dis; 2010; 21(3):995-1003. PubMed ID: 20693641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease.
    Rinne JO; Någren K
    J Alzheimers Dis; 2010; 19(1):291-300. PubMed ID: 20061645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's disease.
    Holmes C; McCulley M; Nicoll JA; Alder JT; Chen CP; Francis PT
    Neurosci Lett; 2007 Jun; 420(1):58-60. PubMed ID: 17481814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Affective symptoms as predictors of Alzheimer's disease in subjects with mild cognitive impairment: a 10-year follow-up study.
    Ramakers IH; Visser PJ; Aalten P; Kester A; Jolles J; Verhey FR
    Psychol Med; 2010 Jul; 40(7):1193-201. PubMed ID: 19903364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET.
    Santhosh L; Estok KM; Vogel RS; Tamagnan GD; Baldwin RM; Mitsis EM; Macavoy MG; Staley JK; van Dyck CH
    Psychiatry Res; 2009 Sep; 173(3):212-7. PubMed ID: 19682865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging beta-amyloid burden in aging and dementia.
    Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
    Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study.
    Hanyu H; Sato T; Hirao K; Kanetaka H; Iwamoto T; Koizumi K
    J Neurol Sci; 2010 Mar; 290(1-2):96-101. PubMed ID: 19931870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).
    Ellis KA; Szoeke C; Bush AI; Darby D; Graham PL; Lautenschlager NT; Macaulay SL; Martins RN; Maruff P; Masters CL; McBride SJ; Pike KE; Rainey-Smith SR; Rembach A; Robertson J; Rowe CC; Savage G; Villemagne VL; Woodward M; Wilson W; Zhang P; Ames D;
    Int Psychogeriatr; 2014 Apr; 26(4):543-54. PubMed ID: 24252258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.